Dopavision appoints Prof. Dr. Jens Ellrich as Chief Scientific Officer
– Leading expert in translational medicine and neuroscience leading Dopavision’s research activities Berlin, Germany, March 21, 2023 — dopavision, a clinical-stage company pioneering the development